Alcohol and Tobacco Consumption in Patients With Head and Neck Cancer : Interest of an Addiction Support

Lung Cancer Clinical Trial

Official title:

Alcohol and TObacco Consumption in Patients With Head and Neck Cancer : Interest of an Addiction Support

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT01652456
• Other study ID #: ALTAKRA - 1205
• Status: Withdrawn
• Phase: N/A
• First received: July 26, 2012
• Last updated: January 23, 2018
• Start date: October 2012
• Est. completion date: November 2017

Study information

• Verified date: August 2014
• Source: Centre Oscar Lambret
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a multicenter, interventional, randomized study for preventive and therapeutic strategies for patients with head and neck or Lung cancer; contribution of an addiction support

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: November 2017
• Est. primary completion date: November 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• first head and neck or lung cancer

• first support

• 18 = age = 60

• lives in Lille Metropolis

• having an addiction to alcohol and tobacco

• covered by health insurance

• signed informed consent

Exclusion Criteria:

• prior cancer

• mesothelioma and oesophageal cancer

• unable to undergo trail medical follow up (geographical, social and psychological reasons)

• pregnant or nursing woman

• patient under guardianship

Related Conditions & MeSH terms

• Behavior, Addictive
• Head and Neck Cancer
• Head and Neck Neoplasms
• Lung Cancer

Intervention

Other:
• Addiction support
one consultation with an addiction specialist

Locations

Country	Name	City	State
France	Centre Hospitalier Régional et Universitaire - Hopital CALMETTE	Lille
France	Centre Hospitalier Régional et Universitaire - Hopital HURIEZ	Lille
France	Oscar Lambret Center	Lille

Sponsors (1)

Lead Sponsor	Collaborator
Centre Oscar Lambret

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	systematic addiction consultation	difference between abstinence in group A and abstinence in group B	12 months after diagnosis
Secondary	progression free survival	median time between date of inclusion and date of first progression	24 months after diagnosis
Secondary	overall survival	median time between date of inclusion and date of death	24 months after survival
Secondary	alcohol and tobacco consumption	frequency of tobacco and alcohol consumption questionnaire : Fagerström, Alcohol Use Disorders Identification Test (AUDIT), Cut Down Annoyed Guilty Eye-Opener (CAGE-DETA), Cannabis abuse screening test (CAST), M.I.N.I.	baseline, 3 months, 6 months and 12 months after diagnosis
Secondary	alcohol + tobacco withdrawal and addiction support	difference between abstinence of group A and abstinence group B	12 months after diagnosis
Secondary	addiction follow up	percentage of patient with a first addiction consultation, and willing to have a long term follow up	24 months after diagnosis